Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Aug 15;17(8):e0272011. doi: 10.1371/journal.pone.0272011

Associations between fully-automated, 3D-based functional analysis of the left atrium and classification schemes in atrial fibrillation

Maurice Pradella 1,2,*, Constantin Anastasopoulos 1, Shan Yang 1, Manuela Moor 1, Patrick Badertscher 3, Julian E Gehweiler 1, Florian Spies 3,4, Philip Haaf 3, Michael Zellweger 3, Gregor Sommer 1,5, Bram Stieltjes 1, Jens Bremerich 1, Stefan Osswald 3,4, Michael Kühne 3,4, Christian Sticherling 3,4, Sven Knecht 3,4
Editor: Vincenzo Lionetti6
PMCID: PMC9377598  PMID: 35969532

Abstract

Background

Atrial fibrillation (AF) has been linked to left atrial (LA) enlargement. Whereas most studies focused on 2D-based estimation of static LA volume (LAV), we used a fully-automatic convolutional neural network (CNN) for time-resolved (CINE) volumetry of the whole LA on cardiac MRI (cMRI). Aim was to investigate associations between functional parameters from fully-automated, 3D-based analysis of the LA and current classification schemes in AF.

Methods

We retrospectively analyzed consecutive AF patients who underwent cMRI on 1.5T systems including a stack of oblique-axial CINE series covering the whole LA. The LA was automatically segmented by a validated CNN. In the resulting volume-time curves, maximum, minimum and LAV before atrial contraction were automatically identified. Active, passive and total LA emptying fractions (LAEF) were calculated and compared to clinical classifications (AF Burden score (AFBS), increased stroke risk (CHA2DS2VASc≥2), AF type (paroxysmal/persistent), EHRA score, and AF risk factors). Moreover, multivariable linear regression models (mLRM) were used to identify associations with AF risk factors.

Results

Overall, 102 patients (age 61±9 years, 17% female) were analyzed. Active LAEF (LAEF_active) decreased significantly with an increase of AFBS (minimal: 44.0%, mild: 36.2%, moderate: 31.7%, severe: 20.8%, p<0.003) which was primarily caused by an increase of minimum LAV. Likewise, LAEF_active was lower in patients with increased stroke risk (30.7% vs. 38.9%, p = 0.002). AF type and EHRA score did not show significant differences between groups. In mLRM, a decrease of LAEF_active was associated with higher age (per year: -0.3%, p = 0.02), higher AFBS (per category: -4.2%, p<0.03) and heart failure (-12.1%, p<0.04).

Conclusions

Fully-automatic morphometry of the whole LA derived from cMRI showed significant relationships between LAEF_active with increased stroke risk and severity of AFBS. Furthermore, higher age, higher AFBS and presence of heart failure were independent predictors of reduced LAEF_active, indicating its potential usefulness as an imaging biomarker.

Introduction

Atrial fibrillation (AF) is the most common arrhythmic heart disease affecting about 1% of the general population and more than 12 million people in the US are expected to have AF by 2030 [1, 2]. This is of clinical importance due to the association of AF with an increased stroke risk, reduction of quality of life and cognitive decline [35]. Several risk factors are associated with the development of AF, including age, AF type, AF Burden and cardiovascular (CV) risk factors such as arterial hypertension (HT), diabetes mellitus, and heart failure (HF) [6]. Furthermore, secondary conditions like hyperthyroidism or lifestyle factors may precipitate AF [7, 8].

Multiple studies have shown that remodeling of the left atrium (LA) with AF leads to its enlargement [911]. However, LA enlargement might not present in some specific AF etiologies [12, 13]. In consequence, current guidelines recommend the assessment of LA size for AF patients, commonly based on the static dimension in parasternal long axis, LA volume (LAV), or indexed LAV (LAVi) [14]. Volumetric parameters are mainly calculated from 2-dimensional data using volumetric approximations such as the area-length method. Besides static LAV assessment, LA function is another important parameter for its characterization. It can be measured from time-resolved (CINE) imaging as strain or LA emptying fractions (LAEF) [15]. The latter was first established based on echocardiography. Recently, preserved LAEF was reported to predict the outcome after HF using cardiac MRI (cMRI) [16]. Moreover, LA function was identified as predictor of CV events and the outcome after myocardial infarction [17, 18]. However, LAEF assessment can be time consuming and requires specific knowledge to preprocess the imaging data.

Artificial intelligence (AI) and specifically deep learning (DL) have proven to support performing LA segmentations on single time point of the cardiac cycle or on post-contrast cMRI with excellent results [19, 20]. DL-based segmentation of the whole LA over the cardiac cycle based on CINE cMRI has also been validated recently for biplane and 3D-based assessment [21]. But this technique has not been applied in a patient cohort to investigate associations with clinical parameters.

The aims of this study were twofold. First, to assess the application of a fully-automatic approach to quantify LA functional parameters based on cMRI in a cohort of AF patients. Second, to investigate its associations with established and novel clinical classification schemes of AF and CV risk factors.

Materials and methods

Study population

The study was approved by the local ethics committee (Ethikkommission Nordwest- und Zentralschweiz (EKNZ)) and complied with the Declaration of Helsinki. Patients gave written informed consent. We considered 181 consecutive patients with CINE MRI from our prospective AF cohort (SWISS AF PVI, Clinical Trial registry) retrospectively. Exclusion criteria were any prior LA ablation and AF during the cMRI. In addition, we performed a comprehensive analysis on all patients, excluding only patients with prior LA ablation. From study records, we extracted CV risk factors (HF, HT, diabetes, renal failure) and left ventricular ejection fraction (LVEF, based on echocardiography).

Image acquisition

cMRI scans were performed on 1.5T MRI systems (Siemens Avanto or Espree, Siemens Healthineers, Germany). Retrospectively ECG-gated, balanced steady-state free precision CINE sequences in oblique-axial orientation (planning was based on a 4CH scout) were acquired covering the whole LA in up to 12 axial stacks during breathhold (TE: 1.1–1.2ms, flip angle: 58–64°, in-plane resolution: 192x156mm, spatial resolution: 1.8–2.0 x 1.8–2.0mm, slice thickness: 6mm, no section gap) with 25 frames per cardiac cycle. No further long- or short-axis views were included in the study protocol.

Convolutional neural network

The network was described and validated in detail elsewhere [21]. It was built to segment the LA using the area-length method (2D) and on multiple oblique-axial CINE sequences in 4CH orientation (3D); the latter was used in this study. Briefly, manual segmentations were performed by M.P. and S.K. using the oblique-axial CINE stack covering the whole LA in 50 cases (Segment v2.2 R6435, Medviso, Sweden) [22]. These time-resolved segmentations were exported as binary masks, each with 25 images / time points, resulting in 1,250 volumes. These segmentations served as the training dataset for a deep convolutional neural network (CNN), based on a U-Net architecture [23]. An anisotropic, slightly altered version of the original 3D U-Net was implemented for the segmentation of the LA with three resolution layers formed by two pooling and upsampling layers [24]. After training and validation, the resulting network was used to predict the segmentation for all cases. An example case with segmentation at fiducial time points is shown in Fig 1.

Fig 1. LA segmentation performed by the CNN.

Fig 1

A) Example case of LA segmentation performed by the CNN on oblique-axial CINE images. Segmentations are shown at the time point of maximum volume (LAV_max, top), volume before atrial contraction (LAV_preA, center) and minimum volume (LAV_min, bottom). B) Schematic volume-time curve to demonstrate the respective fiducial points for minimum LA Volume (LAV_min), maximum LA Volume (LAV_max), volume before atrial contraction (LAV_preA) and local minimum between LAV_max and LAV_preA (LAV_min2). C) volume-time curve of the case shown in (A) with all fiducial points identified.

LA functional assessment from whole cardiac cycle

LA volume was calculated from the segmented 3D dataset by the sum of all identified LA voxels. This was performed for every time point of the cardiac cycle to create the volume-time curve for the LA (Fig 1). LAV_max and LAV_min were automatically identified. Additional fiducial points were the volume before atrial contraction (LAV_preA) which is defined as the time point just before the atrial contraction assists in emptying the LA [25]. Furthermore, the minimal volume between LAV_max and LAV_preA (LAV_min2) was identified automatically, primarily in order to guide the custom-written computational code (in MATLAB, MathWorks, USA) to perform automatic detection of fiducial points. If all fiducial points were identified, the patient was included in the main analysis. Based on available fiducial points, the total (LAEF_total), active (LAEF_active) and passive LAEF (LAEF_passive) were automatically calculated (Fig 1) [25, 26]:

LAEFtotal(%)=(LAVmax-LAVmin)÷LAVmax*100
LAEFactive(%)=(LAVpreA-LAVmin)÷LAVpreA*100
LAEFpassive(%)=(LAVmax-LAVpreA)÷LAVmax*100

Patients without the fiducial point of LAV_preA due to AF during MRI acquisition were included in the comprehensive analysis. In addition to the absolute volumes, we calculated the respective indexed LAV using the Body Surface Area (BSA) according to the Mosteller formula resulting in maximum (LAVi_max), minimum indexed LA volume (LAVi_min), indexed volume before atrial contraction (LAVi_preA), and indexed minimum volume between LAV_max and LAV_preA (LAVi_min2).

An overview of the entire automatic workflow pipeline can be found in Fig 2.

Fig 2. Overview of automatic workflow.

Fig 2

The automated pipeline for image processing is shown in the dashed rectangle at the top: a stack of oblique axial CINE MRI series in 4CH orientation was processed by the convolutional neural network (CNN) for segmentation of the left atrium (LA). Based on the resulting time-resolved 3D model and LA volume-time curve, the characteristic time points were identified. The resulting functional LA parameters (LA emptying fractions (LAEF)) were available fully-automatic. Those parameters were investigated further in relation to stroke risk (CHA2DS2VASc), atrial fibrillation (AF) Burden (AF Burden Score) and other established AF risk factors.

Classification of atrial fibrillation

Standard classification of AF was performed based on the presentation, duration and spontaneous termination of the AF episodes resulting in the class of paroxysmal, and persistent AF [14]. In the recently proposed “4S-AF” scheme, the stroke risk (based on the CHA2DS2VASc score), symptom severity (EHRA symptom score), and severity of AF Burden were proposed for the structured characterization of AF [14]. Stroke risk was stratified for low-risk (CHA2DS2VASc≤1) and increased risk (CHA2DS2VASc≥2). Classification of the EHRA score was performed as follows: class 1 (no symptoms), class 2 (mild symptoms), class 3 (severe symptoms), class 4 (disabling symptoms). The severity of AF was characterized based on the established classification of paroxysmal and persistent AF and additionally, using an established, symptomatic burden-based classification (AF Burden score (AFBS)). AFBS is a structured clinical assessment to evaluate frequency and duration of AF episodes as well as number of electrical cardioversions [27]. The sum of the frequency [daily (5 points), two or more days a week (4), once a week (3 points), monthly (2 points), <4 times per year (1 point)], the duration of the event [minutes (1 point), hours (2 points), most of the day (3), all day (4 points)], and the number of electrical cardioversions [1 (1 point), 2 (2 points), 3 (3 points), >3 (4 points)] was calculated and grouped as minimal (1–3 points), mild (4–6), moderate (7–9), and severe (≥10) AF Burden.

Statistical analysis

Baseline characteristics of patients are presented as the count and percentage for categorical variables. For comparison of the continuous variables, Shapiro test for normality was performed, followed by either t-test (two groups) or one way ANOVA (more than two groups) in case of normal distribution. If data was not normally distributed, we performed Kruskal Wallis test. If there were more than two groups, posthoc Bonferroni correction was performed. Continuous variables were reported as mean ± standard deviation (SD) for normal distribution or median ± interquartile range (IQR) for non-normal distribution. Discrete variables were compared using Fisher’s exact test.

We used a multivariable linear regression model (mLRM) in a step-wise forward approach, corrected for age, BMI and sex, to investigate the relationship of functional LA parameters with following clinical parameters: AF type, AFBS, EHRA score, CHA2DS2VASc, diagnosis of HT, diabetes, HF, renal failure, and LVEF. Parameters with p-value < 0.1 were considered for the next step in the forward approach. Results of the univariable linear regression models (uLRM) are included in the Supplemental Material. Statistical analyses were performed using SPSS (IBM, USA) and a p-value < 0.05 was considered statistically significant.

Results

Study cohort

We finally analyzed 102 patients with automatically calculated LAEF_total, LAEF_active and LAEF_passive. The segmentation algorithm failed in three patients, in nine patients not all fiducial points could be identified due to multiple extra-systoles during MRI acquisition (Fig 3). The baseline characteristics can be found in Table 1.

Fig 3. Study cohort flowchart.

Fig 3

* We performed an additional comprehensive analysis of all patients independent from rhythm status during MRI (total n = 151, study cohort (n = 102) and patients with AF during MRI (n = 49)). However, assessment of active LA contraction was not possible in this cohort.

Table 1. Baseline data.

n = 102
Age [years] 60.8±8.9
Sex, female 18 (17.6%)
BMI [kg/m2] 26.8±4.0
BSA [m2] 2.02±0.21
Type AF
 Paroxysmal 73 (71.6%)
 Persistent 29 (28.4%)
CV risk factors
 Arterial hypertension 55 (53.9%)
 Heart failure 7 (6.9%)
 Diabetes 7 (6.9%)
 Renal failure 8 (7.8%)
 Myocardial infarction 3 (2.9%)
 Stroke 7 (6.9%)
Smoking status
 Never 41 (40.2%)
 Active 11 (10.8%)
 Former 50 (49.0%)
CHA2DS2VASc
 0 23 (22.5%)
 1 31 (30.4%)
 2 29 (28.4%)
 3 11 (10.8%)
 4 6 (5.9%)
 5 1 (1.0%)
 6 0
CHA2DS2VASc
 Low stroke risk (CHA2DS2VASc ≤ 1) 55 (53.9%)
 Increased stroke risk (CHA2DS2VASc ≥ 2) 47 (46.1%)
EHRA score
 I 8 (8%)
 II 57 (56%)
 III 30 (29%)
 IV 1 (1%)
AF Burden score (AFBS)
 1 8 (7.8%)
 2 65 (63.7%)
 3 23 (22.5%)
 4 5 (4.9%)
LA parameters
LAV_max [ml] 102.5±34.2
LAV_min [ml] 54.3±28.8
LAV_preA [ml] 80.8±30.9
LAV_min2 [ml] 76.3±30.5
LAVi_max [ml/m2] 50.9 ± 16.1
LAVi_min [ml/m2] 27.0 ± 14.3
LAVi_preA [ml/m2] 40.1±14.7
LAVi_min2 [ml/m2] 37.9±14.8
LAEF_total [%] 48.6±12.1
LAEF_active [%] 35.2±12.2
LAEF_passive [%] 21.7±7.9
LVEF [%] 57.4±8.0

Association of functional parameters with stroke risk based on CHA2DS2VASc

The three functional parameters LAEF_total, LAEF_active, and LAEF_passive were all significantly lower for increased stroke risk (CHA2DS2VASc ≥2; p<0.001, p = 0.002 and p<0.001, respectively; Fig 4, Table 2). This was based upon significant increases in minimum LAV parameters (LAV_min, LAV_preA, LAVi_min, LAVi_preA). A detailed CHA2DS2VASc comparison for all categories can be found in the S1 Table.

Fig 4. LA functional parameters and stroke risk based on CHA2DS2VASc.

Fig 4

LAEF_total, LAEF_active and LAEF_passive in relation to low and increased stroke risk (based on CHA2DS2VASc score of ≤ 1 or ≥ 2). All three parameters were significantly lower in the group with increased stroke risk based on the CHA2DS2VASc. LAEF–left atrial emptying fraction.

Table 2. Functional associations with low and increased stroke risk based on CHA2DS2VASc.

CHA2DS2VASc based stroke risk
Stroke risk [patients] Low (CHA2DS2VASc ≤ 1) [55] Increased (CHA2DS2VASc ≥ 2) [47] p value
LAV_max [ml], mean ± SD 99.3 ± 34.6 106.4 ± 33.6 0.30
LAV_min [ml], median ± IQR 42.9 ± 22.7 57.2 ± 34.7 0.004
LAV_preA [ml], median ± IQR 70.7 ± 33.2 83.0 ± 30.6 0.01
LAV_min2 [ml], median ± IQR 64.7 ± 28.8 81.4 ± 32.2 0.003
LAVi_max [ml/m2], mean ± SD 48.2 ± 14.4 54.1 ± 17.4 0.06
LAVi_min [ml/m2], median ± IQR 22.8 ± 9.1 31.9 ± 17.5 0.002
LAVi_preA [ml/m2], median ± IQR 35.5 ± 12.2 43.6 ± 16.7 0.005
LAVi_min2 [ml/m2], median ± IQR 32.1 ± 12.8 40.7 ± 17.7 0.001
LAEF_total [%], median ± IQR 54.4 ± 11.4 45.8 ± 13.2 <0.001
LAEF_active [%], median ± IQR 37.8 ± 11.7 30.5 ± 15.6 0.002
LAEF_passive [%], median ± IQR 24.5 ± 9.1 18.5 ± 7.3 <0.001

LAEF–Left atrial emptying fraction, LAV–Left atrial volume, LAVi–Left atrial volume index

Association of functional parameters with severity of atrial fibrillation burden

LAEF_total and LAEF_active significantly decreased with increase of AFBS (p = 0.002 and p = 0.003, respectively) (Table 3). For LAEF_total, a posthoc test revealed significant differences between AF Burden categories 1 vs. 3 (p = 0.007), 1 vs. 4 (p = 0.04), 2 vs. 3 (p = 0.04), and 2 vs. 4 (p = 0.007). For LAEF_active, significant differences were found between AF Burden categories 1 vs. 3 (p = 0.02), 1 vs. 4 (p = 0.01), and 2 vs. 4 (p = 0.005) (Fig 5). LAEF_passive was not significantly different between groups. This was mainly driven by significant increases of LAV_min, LAVi_min and LAVi_preA when AF Burden increase (p<0.001, p<0.001, p = 0.01, respectively), whereas the maximum LAV parameters did not show significant differences.

Table 3. Functional associations with AF Burden score.

AF Burden score [patients] 1 [8] 2 [65] 3 [23] 4 [5] p value
LAV_max [ml], median ± IQR 84.5 ± 35.6 103.5 ± 38.8 97.8 ± 44.6 117.9 ± 24.4 0.36
LAV_min [ml], mean ± SD 37.9 ± 14.3 52.3 ± 20.4 56.4 ± 24.9 99.3 ± 85.6 <0.001
LAV_preA [ml], median ± IQR 69.2 ± 32.9 79.5 ± 32.3 76.3 ± 47.7 98.8 ± 42.9 0.42
LAV_min2 [ml], median ± IQR 60.9 ± 32.8 74.9 ± 33.0 69.3 ± 43.3 96.8 ± 46.4 0.45
LAVi_max [ml/m2], median ± IQR 41.1 ± 10.7 50.9 ± 19.6 45.2 ± 22.0 55.8 ± 22.8 0.20
LAVi_min [ml/m2], mean ± SD 18.9 ± 5.9 25.7 ± 9.6 28.5 ± 12.5 51.1 ± 42.7 <0.001
LAVi_preA [ml/m2], mean ± SD 33.3 ± 6.2 39.4 ± 11.8 40.4 ± 12.5 59.6 ± 42.0 0.01
LAVi_min2 [ml/m2], mean ± SD 31.0 ± 7.2 37.0 ± 11.4 38.8 ± 12.4 58.1 ± 43.2 0.009
LAEF_total [%], mean ± SD 57.2 ± 10.3 49.8 ± 10.3 44.5 ± 10.9 34.9 ± 24.6 0.002
LAEF_active [%], mean ± SD 44.0 ± 11.0 36.2 ± 11.0 31.7 ± 11.8 20.8 ± 17.5 0.003
LAEF_passive [%], mean ± SD 24.2 ± 5.6 22.3 ± 7.8 18.7 ± 5.9 20.3 ± 15.4 0.19

LAEF–Left atrial emptying fraction, LAV–Left atrial volume, LAVi–Left atrial volume index

Fig 5. LA functional parameters and AFBS.

Fig 5

LAEF_total, LAEF_active and LAEF_passive in relation to the AFBS categories. Both LAEF_total and LAEF_active significantly decreased with AFBS increase while LAEF_passive did not show significant differences. LAEF–left atrial emptying fraction. AFBS–AF Burden score. Post hoc tests: * = p<0.05, ** = p<0.01.

Association of functional parameters with symptom severity & atrial fibrillation type

No significant differences was observed between EHRA score or AF type (paroxysmal or persistent AF) and any of the LA parameters (S2 and S3 Tables).

Prediction of functional left atrial parameters

Multivariable linear regression models were computed for total, active and passive LAEF in relation to the classification of AF based (stroke risk (CHA2DS2VASc score), symptom severity (EHRA score), severity of AF Burden (type of AF and AFBS)) and CV risk factors. The results from univariable LRM can be found in the S4S6 Tables.

Total, active and passive LAEF and AF risk factors

The mLRM was corrected for age, sex, BMI and showed that LAEF_total decreased per year of age by -0.49% (95%CI: -0.71, -0.27, p<0.001), in the presence of HF by -14.23% (95%CI: -23.82, -4.64, p = 0.004) and diagnosis of HT by -5.51% (95%CI: -9.80, -1.23), p = 0.01) (Table 4); excluded parameters can be found in the S7S9 Tables.

Table 4. Multivariable linear regression analyses for predicting factors.
Parameter Variable B 95% CI P value
Total LAEF (Intercept) 75.98 57.27, 94.69 <0.001
Age -0.49 -0.71, -0.27 <0.001
Male Sex 3.79 -1.62, 9.19 0.17
BMI -0.01 -0.53, 0.51 0.96
Heart failure -14.23 -23.82, -4.64 0.004
R2 adjusted: 0.32 Arterial hypertension -5.51 -9.80, -1.23 0.01
Active LAEF (Intercept) 61.82 39.43, 84.21 <0.001
Age -0.32 -0.58, -0.05 0.02
Male Sex 2.80 -3.40, 8.99 0.37
BMI 0.02 -0.55, 0.58 0.96
AF Burden -4.20 -7.88, -0.53 0.026
R2 adjusted: 0.22 Heart failure -12.12 -23.61, -0.63 0.039
Passive LAEF (Intercept) 18.10 -3.52, 39.72 0.10
Age -0.27 -0.45, -0.09 0.003
Male Sex 2.28 -2.01, 6.57 0.29
BMI 0.05 -0.34, 0.45 0.78
R2 adjusted: 0.14 LVEF 0.29 0.06, 0.53 0.014

95% CI– 95% Confidence interval, AF–Atrial fibrillation, BMI–Body mass index, LAEF–left atrial emptying fraction, LVEF–Left ventricular ejection fraction.

The corrected mLRM for LAEF_active showed a decrease per year of age by -0.32% (95% CI: -0.58, -0.05, p = 0.02), for each increase in AFBS category by -4.20% (95%CI: -7.88, -0.53, p = 0.026) and in the presence of HF by -12.12% (95% CI: -23.61, -0.63, p = 0.039) (Table 4). The significance of CHA2DS2VASc, quality of life, renal failure, HT and LVEF in the uLRM vanished in the multivariable approach (see Supplemental Material).

In contrast, the model for LAEF_passive only included a decrease by -0.27% (95%CI: -0.45, -0.09), p = 0.003) per year of age and an increase by 0.29% (95%CI: 0.06, 0.53), p = 0.014) per each percent of LVEF (Table 4). The effects of CHA2DS2VASc, HF and HT in the univariable models did not prevail in the multivariable model.

We note that the classical differentiation between paroxysmal and persistent AF (AF type) and EHRA score did not have an impact on any parameter for both uLRM or mLRM.

Comprehensive analysis

The baseline characteristics from the comprehensive analysis of the entire cohort (n = 151 patients), including the patients in AF during MR acquisition, can be found in the Supplemental Material. Due to the 49 patients with AF during the MRI acquisition without active LA contraction, we could only investigate LAV_max, LAV_min, LAEF_total as well as LAVi_max and LAVi_min in all patients. In this cohort, we observed more patients with persistent AF and also overall higher AFBS (see S10 Table). AFBS and stroke risk based on CHA2DS2VASc were lower in patients with lower LAV_min (p<0.001, p = 0.01; respectively), lower LAVi_min (p<0.001, p<0.001; respectively) and higher total LAEF (p<0.001, p<0.001; respectively); S11 and S12 Tables. On opposite, LAV_max was not significantly different for AFBS and CHA2DS2VASc-based stroke risk. We also observed that patients with persistent AF had higher minimum and maximum volumes (both indexed and absolute) and a lower total LAEF; S13 Table. Lastly, EHRA score did not show significant differences; S14 Table.

Discussion

In this study, we investigated LA functional parameters using a fully-automatic, 3D-based volumetric assessment of the whole cardiac cycle of the LA with a comprehensive clinical AF classification scheme. The main observations of our study were:

  1. The application of the previously validated, CNN-based segmentation algorithm was feasible for 3D segmentation in all except three patients. Overall, automatic detection of fiducial points from the resulting volume-time curve was possible in 102/114 patients (92%), allowing to automatically differentiate between total, active and passive LAEF.

  2. We identified strong association of the LA function with AFBS and stroke risk based on CHA2DS2VASc. In detail, LAEF_total and LAEF_active both showed a significant decline with increasing AFBS. In addition, patients with a lower total, active and passive LAEF presented with an increased stroke risk according to the CHA2DS2VASc. For all those associations, the increase of LAV_min rather than an increase of LAV_max (for LAEF_total) or LAV_preA (for LAEF_active) seemed to be the underlying mechanism. Results from the entire cohort including patients in AF during the MRI and therefore without active LA contraction did not differ substantially from these observations.

  3. Multivariable regression analyses, corrected for age, BMI and sex, revealed relationships between total, active and passive LAEF with established AF risk factors. Especially higher age was an independent predictor of a reduction of all three LAEF parameters in our AF cohort. In addition, a higher AFBS was an independent predictor of reduced LAEF_active, HT was an independent predictor of reduced LAEF_total, and HF independently predicted reduced active and total LAEF.

Applicability of the approach

LA size measured as maximum diameter in parasternal long axis by echocardiography at ventricular end-systole is an established parameter and was identified as predictor for AF in the Framingham Study [28]. For LAV assessment, superiority of cMRI over echocardiography was shown in the past while other techniques such as 3D mapping system also allow LA volumetry [2931]. The vast majority of cMRI studies, however, used biplanar-based calculation for volumetric analysis of the LA with a focus on maximum (indexed) volume [16, 17, 32, 33]. Longer acquisition times for 3D coverage of the LA and the time-consuming manual LA segmentation might explain the limited number of cMRI studies analyzing LA function based on 3D datasets in the past [29, 34, 35]. Recently, there were reports of AI tools segmenting the LA on CINE series for biplane or short axis-based assessment but not for oblique-axial orientation [3638]. To overcome this limitation, we recently validated a CNN-based algorithm for LA segmentation over the whole cardiac cycle. This algorithm has two elements, one for biplane-based LA segmentation and one for 3D-based LA segmentation on oblique-axial CINE series [21]; the latter was used in this study. Volume-time curves were generated from the segmentations and characteristic fiducial points automatically identified, which was possible in 102 patients. The reason for failed identification of fiducial points were rhythm irregularities (numerous extra-systoles) during image acquisition. Real-time CINE imaging could generally be an option to overcome arrhythmias, however, these were not acquired in this study. Due to low image resolution, volumetric assessment and therefore LAEF assessment could be compromised by real-time imaging.

Overall, automatic calculation of LAEF_total, LAEF_active and LAEF_passive could be achieved in 102 patients with sinus-rhythm during cMRI from a standard clinical protocol. This showed applicability of our comprehensive approach and represents an example of a fully automated, DL-supported workflow supporting a complex, cMRI-based analysis. However, in patients with AF during MRI acquisition, assessment of LAEF_active is not possible. Instead, our comprehensive analysis suggested that LAEF_total might serve as an alternative biomarker in this cohort.

LA volumes and LAEF as measures for LA size and function and their clinical implications

Single time point-based analysis of LA volume is common in clinical practice since LA enlargement was linked to multiple CV diseases [39]. However, the potential superiority of LAEF as a functional parameter over a static LAV alone was proposed by Hoit who linked it to the importance of minimum LAV [39]. LAEF combines distinct measures of LAV_max, LAV_min and/or LAV_preA in one parameter and, therefore, strengthens the advantage of CINE analysis over single time point assessment. LAEF was already associated with silent strokes, HF and cardiomyopathies [15, 32, 33]. In patients with diagnosis of AF, Sievers et al. reported a mean total LAEF of 49.8% (in sinus rhythm) based on 3D assessment, respectively [34]; these results match our findings well (48.6%). Wandelt et al. performed manual 3D segmentations based on axial CINE series in an AF patient cohort. The reported mean values for LAEF_total, LAEF_active and LAEF_passive of 47.9%, 35.6% and 19.2%, respectively, were similar to our results (48.6%, 35.2% and 21.7%, respectively) [40].

LA function and AF burden

AF Burden is an important parameter to assess and classify AF patients [14]. In addition to the categorization in paroxysmal and persistent AF, we included AFBS, which characterizes AF Burden in more detail by combining frequency and duration of AF episodes as well as the number of cardioversions. These characteristics proved to be able to predict AF recurrence after first and repeated PVI better than the classic AF characterization [27]. In line with this observation, the AFBS, but not the conventional classification in paroxysmal and persistent AF, showed a significant relationship to active and total LAEF in this study. Accordingly, mLRM results showed a significant reduction of LAEF_active by -4.2% with each increase of AFBS category. These results were driven by a bigger difference of minimum volume rather than LAV_max for LAEF_total or LAV_preA for LAEF_active. The correlation of LAEF_active reduction with AFBS increase might be explained by the fact that a “healthier” (less remodeled) LA was able to actively pump more blood from the LA into the left ventricle at the end of ventricular diastole, resulting in a lower minimum LA volume. Other studies observed associations of decreased LAEF_active with non-obstructive, hypertrophic cardiomyopathy prior to LA enlargement and adverse effects and death in hypertensive patients [15, 41]. Our data suggested that LAEF_total and LAEF_active might play in addition an important role in assessment of AF patients, at least if they are in sinus rhythm during MRI.

LA function and stroke risk based on CHA2DS2VASc

Patients with AF suffer a 5-fold increased risk of stroke caused by thrombus formations in the LA and LA appendage [11]. The CHA2DS2VASc score as a measure of the stroke risk in AF patients showed another important association with LA function in our study: In patients with an increased risk for stroke (based on a CHA2DS2VASc ≥ 2), total, active and passive LAEF were significantly lower compared to low-risk patients (CHA2DS2VASc ≤ 1). This indicated that a reduced LA function was associated with an increased risk for stroke in AF patients. In fact, all 7 patients with a reported stroke in our cohort had a CHA2DS2VASc ≥ 2. This is in accordance with the current literature where a reduction of LAEF_total was linked to cerebrovascular events or in patients suffering a stroke [33, 42]. In accordance with our observation, Leung et al. stated that LA function could provide additional risk stratification for stroke in patient with a high CHA2DS2VASc score of ≥2 [43].

LA function and other AF risk factors

In a separate analysis, we furthermore identified significant relationships between established AF risk factors and the three LAEF parameters (LAEF_total, LAEF_active, LAEF_passive). In detail, the mLRM (corrected for age, BMI and sex), revealed a statistically significant, negative correlation of age with all three LAEF parameters. This is in accordance to the known importance of age as a risk factor for AF [44]. Arterial hypertension and HF which are other known, major AF risk factors, were also independent predictors of reduced total and active LAEF [39, 41]. Opposite, LVEF was (besides age) the only parameter to independently predictor a higher LAEF_passive. This in line with the fact that LAEF_passive is mainly determined by LV functionality [39, 45]. Of note, LAEF_passive cannot accurately assess the conduit function of the LA because blood can pass through the LA directly from the pulmonary veins without changing the current LA volume [39]. In summary, age, HT, HF and to a certain amount LVEF, are relevant, independent predictors of the LA function.

Limitations

This was a single-center, retrospectively analyzed study from a prospective cohort, therefore generalizability of our results might be limited. AFBS is partially a subjective score, patients without or with milder symptoms could be underrepresented.

When we planned this study, we focused on LA volumes assessment in 3D. Therefore, we only have oblique-axial CINE series available in this cohort and could not compare our parameters to biplane assessment of LA function which was a tradeoff to allow for 3D image acquisition.

The applied, previously established CNN for LA segmentation was built in-house on imaging data from one vendor. While openly accessible, the transferability on imaging studies from other institutions cannot be guaranteed.

We investigated only patients whose volume-time curves had all fiducial points available. This restricted the generalizability of the results to patients in SR at the time of cMRI which might have caused a bias regarding patient selection, for example this could have limited the number of patients with persistent AF (28% of all patients). To address this limitation, we performed the comprehensive analysis of the entire cohort, including patients with AF during the acquisition. Furthermore, we investigated the risk for stroke based on the CHA2DS2VASc and not based on the clinical event of a stroke. The CHA2DS2VASc was also not homogenously distributed in our rather young patient cohort.

We did not perform continuous rhythm monitoring before the MRI; therefore, a reduced LA function might as well be a result of LA stunning due to previous spontaneous termination of AF. Furthermore, short paroxysmal episodes of AF could have happened during MRI and could have led to a missing atrial contraction, resulting in exclusion of these patients. Finally, an adjustment for multiple testing was not performed due to the exploratory nature of the comparison.

Conclusions

Our study showed that the fully-automatic characterization of LA function from 3D-based CINE cMRI is feasible in a clinical cohort of patients with diagnosis of AF. It revealed significant associations between LA functional parameters, especially active LAEF, with increased stroke risk (based on the CHA2DS2VASc score) and the severity of the AF Burden. This indicates potential usefulness of active LAEF as an imaging biomarker, though its effect on clinical endpoints such as recurrence of AF, hospitalization, stroke, or mortality, requires evaluation in further studies.

Supporting information

S1 Table. Functional associations with CHA2DS2VASc.

LAEF parameters were significantly different between the CHA2DS2VASc categories.

(DOCX)

S2 Table. Functional associations with EHRA score.

No significant differences were seen between volumetric or functional parameters.

(DOCX)

S3 Table. Functional associations with AF type.

No significant differences were seen between volumetric or functional parameters.

(DOCX)

S4 Table. Total LAEF—Excluded variables from multivariable regression analysis.

(DOCX)

S5 Table. Active LAEF—Excluded variables from multivariable regression analysis.

(DOCX)

S6 Table. Passive LAEF—Excluded variables from multivariable regression analysis.

(DOCX)

S7 Table. Univariable linear regression analyses for total LAEF.

(DOCX)

S8 Table. Univariable linear regression analyses for active LAEF.

(DOCX)

S9 Table. Univariable linear regression analyses for passive LAEF.

(DOCX)

S10 Table. Comprehensive analysis of the entire cohort.

Baseline characteristics.

(DOCX)

S11 Table. Comprehensive analysis, AF Burden score.

Absolute and indexed minimum LA volume and LAEF_total were significantly different between groups while LAV_max was not.

(DOCX)

S12 Table. Comprehensive analysis, CHA2DS2VASc based stroke risk.

Absolute and indexed minimum LA volume and LAEF_total were significantly different between groups while LAV_max was not.

(DOCX)

S13 Table. Comprehensive analysis, AF type.

LA volumes (minimum and maximum) were higher and LAEF_total lower in patients with persistent AF.

(DOCX)

S14 Table. Comprehensive analysis, EHRA score.

We did not find significant differences between EHRA Score and LA measures.

(DOCX)

S1 Data. Minimal data set.

(XLSX)

Acknowledgments

The CNN (“Atri-U”) for segmentation is available as a stand-alone, backend version online (https://git.upd.unibe.ch/openscience/atri-u) [21].

The computational code for detection of the fiducial time points in the volume-time curves is also available online (https://github.com/Manibu4/Cardio_matlab_script.git).

Patient data incl. MRI scans underlying this article cannot be shared publicly due to privacy reasons under Swiss law. Data might be shared on reasonable request to the corresponding author, but is subject to prior approval by the local ethics committee.

Abbreviations

2D

2-dimensional

3D

3-dimensional

AF

Atrial fibrillation

AFBS

AF Burden Score

AI

Artificial intelligence

BMI

Body mass index

BSA

Body surface area

cMRI

Cardiac Magnetic Resonance Imaging

CNN

Convolutional Neural Network

CV

Cardiovascular

DL

Deep learning

ECG

Electrocardiogram

EHRA

European Heart Rhythm Association

HF

Heart failure

HT

Arterial hypertension

LA

Left atrium

LAEF

Left atrial emptying fraction

LAEF_active

Active LAEF

LAEF_passive

Passive LAEF

LAEF_total

Total LAEF

LAV

Left atrial volume

LAV_max

Maximum left atrial volume

LAV_min

Minimum left atrial volume

LAV_min2

Left atrial volume, local minimum

LAV_preA

Left atrial volume before atrial contraction

LAVi

Left atrial volume index

LAVi_max

Indexed maximum left atrial volume

LAVi_min

Minimum left atrial volume index

LAVi_min2

Left atrial volume indexed, local minimum

LAVi_preA

Left atrial volume index before atrial contraction

LVEF

Left ventricular ejection fraction

mLRM

Multivariable linear regression model

SD

Standard deviation

SR

Sinus rhythm

TE

Echo time

uLRM

Univariable linear regression model

Data Availability

We have added a minimal data set of all participants and parameters used for the statistical analysis. There are restrictions on accessing the MRI data. In order to apply for access to the MRI data, please reach out to: Rebecca Paladini Project Coordinator Swiss-AF Petersgraben 4 4031 Basel Switzerland Email: Rebecca.Paladini@usb.ch.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014;11(11):639–54. doi: 10.1038/nrcardio.2014.118 [DOI] [PubMed] [Google Scholar]
  • 2.Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–7. doi: 10.1016/j.amjcard.2013.05.063 [DOI] [PubMed] [Google Scholar]
  • 3.Passman R, Bernstein RA. New Appraisal of Atrial Fibrillation Burden and Stroke Prevention. Stroke. 2016;47(2):570–6. doi: 10.1161/STROKEAHA.115.009930 [DOI] [PubMed] [Google Scholar]
  • 4.Blum S, Muff C, Aeschbacher S, Ammann P, Erne P, Moschovitis G, et al. Prospective Assessment of Sex-Related Differences in Symptom Status and Health Perception Among Patients With Atrial Fibrillation. J Am Heart Assoc. 2017;6(7). doi: 10.1161/JAHA.116.005401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kalantarian S, Stern TA, Mansour M, Ruskin JN. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med. 2013;158(5 Pt 1):338–46. doi: 10.7326/0003-4819-158-5-201303050-00007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr., et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019;140(2):e125–e51. doi: 10.1161/CIR.0000000000000665 [DOI] [PubMed] [Google Scholar]
  • 7.Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med. 2004;164(15):1675–8. doi: 10.1001/archinte.164.15.1675 [DOI] [PubMed] [Google Scholar]
  • 8.Mont L, Elosua R, Brugada J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace. 2009;11(1):11–7. doi: 10.1093/europace/eun289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Tsang TS, Barnes ME, Bailey KR, Leibson CL, Montgomery SC, Takemoto Y, et al. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc. 2001;76(5):467–75. doi: 10.4065/76.5.467 [DOI] [PubMed] [Google Scholar]
  • 10.Pritchett AM, Jacobsen SJ, Mahoney DW, Rodeheffer RJ, Bailey KR, Redfield MM. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol. 2003;41(6):1036–43. doi: 10.1016/s0735-1097(02)02981-9 [DOI] [PubMed] [Google Scholar]
  • 11.Delgado V, Di Biase L, Leung M, Romero J, Tops LF, Casadei B, et al. Structure and Function of the Left Atrium and Left Atrial Appendage: AF and Stroke Implications. J Am Coll Cardiol. 2017;70(25):3157–72. doi: 10.1016/j.jacc.2017.10.063 [DOI] [PubMed] [Google Scholar]
  • 12.Mascia G, Della Bona R, Ameri P, Canepa M, Porto I, Brignole M. Brugada syndrome and syncope: A systematic review. J Cardiovasc Electrophysiol. 2020;31(12):3334–8. doi: 10.1111/jce.14787 [DOI] [PubMed] [Google Scholar]
  • 13.Platonov PG, McNitt S, Polonsky B, Rosero SZ, Zareba W. Atrial Fibrillation in Long QT Syndrome by Genotype. Circ Arrhythm Electrophysiol. 2019;12(10):e007213. doi: 10.1161/CIRCEP.119.007213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373–498. doi: 10.1093/eurheartj/ehaa612 [DOI] [PubMed] [Google Scholar]
  • 15.Yang Y, Yin G, Jiang Y, Song L, Zhao S, Lu M. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study. J Cardiovasc Magn Reson. 2020;22(1):1. doi: 10.1186/s12968-019-0589-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kanagala P, Arnold JR, Cheng ASH, Singh A, Khan JN, Gulsin GS, et al. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction. Int J Cardiovasc Imaging. 2020;36(1):101–10. doi: 10.1007/s10554-019-01684-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Schuster A, Backhaus SJ, Stiermaier T, Navarra JL, Uhlig J, Rommel KP, et al. Left Atrial Function with MRI Enables Prediction of Cardiovascular Events after Myocardial Infarction: Insights from the AIDA STEMI and TATORT NSTEMI Trials. Radiology. 2019;293(2):292–302. doi: 10.1148/radiol.2019190559 [DOI] [PubMed] [Google Scholar]
  • 18.Leng S, Ge H, He J, Kong L, Yang Y, Yan F, et al. Long-term Prognostic Value of Cardiac MRI Left Atrial Strain in ST-Segment Elevation Myocardial Infarction. Radiology. 2020;296(2):299–309. doi: 10.1148/radiol.2020200176 [DOI] [PubMed] [Google Scholar]
  • 19.Pop M, Sermesant M, Zhao J, Li S, McLeod K, Young A, et al. Statistical Atlases and Computational Models of the Heart. Atrial Segmentation and LV Quantification Challenges 9th International Workshop, STACOM 2018, Held in Conjunction with MICCAI 2018, Granada, Spain, September 16, 2018, Revised Selected Papers. Cham: Springer International Publishing; 2019.
  • 20.Jamart K, Xiong Z, Maso Talou GD, Stiles MK, Zhao J. Mini Review: Deep Learning for Atrial Segmentation From Late Gadolinium-Enhanced MRIs. Front Cardiovasc Med. 2020;7:86. doi: 10.3389/fcvm.2020.00086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Anastasopoulos C, Yang S, Pradella M, Akinci D’Antonoli T, Knecht S, Cyriac J, et al. Atri-U: assisted image analysis in routine cardiovascular magnetic resonance volumetry of the left atrium. J Cardiovasc Magn Reson. 2021;23(1):133. doi: 10.1186/s12968-021-00791-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Heiberg E, Sjogren J, Ugander M, Carlsson M, Engblom H, Arheden H. Design and validation of Segment—freely available software for cardiovascular image analysis. BMC Med Imaging. 2010;10:1. doi: 10.1186/1471-2342-10-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ronneberger O, Fischer P, Brox T, editors. U-Net: Convolutional Networks for Biomedical Image Segmentation2015; Cham: Springer International Publishing.
  • 24.Çiçek Ö, Abdulkadir A, Lienkamp SS, Brox T, Ronneberger O, editors. 3D U-Net: Learning Dense Volumetric Segmentation from Sparse Annotation2016; Cham: Springer International Publishing.
  • 25.Zareian M, Ciuffo L, Habibi M, Opdahl A, Chamera EH, Wu CO, et al. Left atrial structure and functional quantitation using cardiovascular magnetic resonance and multimodality tissue tracking: validation and reproducibility assessment. J Cardiovasc Magn Reson. 2015;17:52. doi: 10.1186/s12968-015-0152-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kowallick JT, Kutty S, Edelmann F, Chiribiri A, Villa A, Steinmetz M, et al. Quantification of left atrial strain and strain rate using Cardiovascular Magnetic Resonance myocardial feature tracking: a feasibility study. J Cardiovasc Magn Reson. 2014;16:60. doi: 10.1186/s12968-014-0060-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Knecht S, Pradella M, Reichlin T, Muhl A, Bossard M, Stieltjes B, et al. Left atrial anatomy, atrial fibrillation burden, and P-wave duration-relationships and predictors for single-procedure success after pulmonary vein isolation. Europace. 2018;20(2):271–8. doi: 10.1093/europace/euw376 [DOI] [PubMed] [Google Scholar]
  • 28.Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89(2):724–30. doi: 10.1161/01.cir.89.2.724 [DOI] [PubMed] [Google Scholar]
  • 29.Mor-Avi V, Yodwut C, Jenkins C, Kuhl H, Nesser HJ, Marwick TH, et al. Real-time 3D echocardiographic quantification of left atrial volume: multicenter study for validation with CMR. JACC Cardiovasc Imaging. 2012;5(8):769–77. doi: 10.1016/j.jcmg.2012.05.011 [DOI] [PubMed] [Google Scholar]
  • 30.Giaccardi M, Anselmino M, Del Greco M, Mascia G, Paoletti Perini A, Mascia P, et al. Radiation awareness in an Italian multispecialist sample assessed with a web-based survey. Acta Cardiol. 2021;76(3):307–11. doi: 10.1080/00015385.2020.1733303 [DOI] [PubMed] [Google Scholar]
  • 31.Sarkozy A, De Potter T, Heidbuchel H, Ernst S, Kosiuk J, Vano E, et al. Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS). EP Europace. 2017;19(12):1909–22. [DOI] [PubMed] [Google Scholar]
  • 32.Pellicori P, Zhang J, Lukaschuk E, Joseph AC, Bourantas CV, Loh H, et al. Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value. Eur Heart J. 2015;36(12):733–42. doi: 10.1093/eurheartj/ehu405 [DOI] [PubMed] [Google Scholar]
  • 33.Habibi M, Zareian M, Ambale Venkatesh B, Samiei S, Imai M, Wu C, et al. Left Atrial Mechanical Function and Incident Ischemic Cerebrovascular Events Independent of AF: Insights From the MESA Study. JACC Cardiovasc Imaging. 2019;12(12):2417–27. doi: 10.1016/j.jcmg.2019.02.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sievers B, Kirchberg S, Addo M, Bakan A, Brandts B, Trappe HJ. Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP. J Cardiovasc Magn Reson. 2004;6(4):855–63. doi: 10.1081/jcmr-200036170 [DOI] [PubMed] [Google Scholar]
  • 35.Maceira AM, Cosin-Sales J, Roughton M, Prasad SK, Pennell DJ. Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:65. doi: 10.1186/1532-429X-12-65 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lourenço A, Kerfoot E, Dibblin C, Alskaf E, Anjari M, Bharath AA, et al., editors. Left Atrial Ejection Fraction Estimation Using SEGANet for Fully Automated Segmentation of CINE MRI2021; Cham: Springer International Publishing.
  • 37.Lourenco A, Kerfoot E, Dibblin C, Chubb H, Bharath A, Correia T, et al. Automatic estimation of left atrial function from short axis CINE-MRI using machine learning. Eur Heart J. 2020;41(Supplement_2). [Google Scholar]
  • 38.Uslu F, Varela M, editors. SA-Net: A Sequence Aware Network for the Segmentation of the Left Atrium in Cine MRI Datasets. 2021 IEEE 18th International Symposium on Biomedical Imaging (ISBI); 2021 13–16 April 2021.
  • 39.Hoit BD. Left atrial size and function: role in prognosis. J Am Coll Cardiol. 2014;63(6):493–505. doi: 10.1016/j.jacc.2013.10.055 [DOI] [PubMed] [Google Scholar]
  • 40.Wandelt LK, Kowallick JT, Schuster A, Wachter R, Stumpfig T, Unterberg-Buchwald C, et al. Quantification of left atrial volume and phasic function using cardiovascular magnetic resonance imaging-comparison of biplane area-length method and Simpson’s method. Int J Cardiovasc Imaging. 2017;33(11):1761–9. doi: 10.1007/s10554-017-1160-9 [DOI] [PubMed] [Google Scholar]
  • 41.Kaminski M, Steel K, Jerosch-Herold M, Khin M, Tsang S, Hauser T, et al. Strong cardiovascular prognostic implication of quantitative left atrial contractile function assessed by cardiac magnetic resonance imaging in patients with chronic hypertension. J Cardiovasc Magn Reson. 2011;13(1):42. doi: 10.1186/1532-429X-13-42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Biering-Sørensen T, Christensen LM, Krieger DW, Mogelvang R, Jensen JS, Højberg S, et al. LA Emptying Fraction Improves Diagnosis of Paroxysmal AF After Cryptogenic Ischemic Stroke: Results From the SURPRISE Study. JACC Cardiovasc Imaging. 2014;7(9):962–3. doi: 10.1016/j.jcmg.2014.02.003 [DOI] [PubMed] [Google Scholar]
  • 43.Leung M, van Rosendael PJ, Abou R, Ajmone Marsan N, Leung DY, Delgado V, et al. Left atrial function to identify patients with atrial fibrillation at high risk of stroke: new insights from a large registry. Eur Heart J. 2017;39(16):1416–25. [DOI] [PubMed] [Google Scholar]
  • 44.Weng LC, Preis SR, Hulme OL, Larson MG, Choi SH, Wang B, et al. Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation. Circulation. 2018;137(10):1027–38. doi: 10.1161/CIRCULATIONAHA.117.031431 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Barbier P, Solomon SB, Schiller NB, Glantz SA. Left atrial relaxation and left ventricular systolic function determine left atrial reservoir function. Circulation. 1999;100(4):427–36. doi: 10.1161/01.cir.100.4.427 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Table. Functional associations with CHA2DS2VASc.

LAEF parameters were significantly different between the CHA2DS2VASc categories.

(DOCX)

S2 Table. Functional associations with EHRA score.

No significant differences were seen between volumetric or functional parameters.

(DOCX)

S3 Table. Functional associations with AF type.

No significant differences were seen between volumetric or functional parameters.

(DOCX)

S4 Table. Total LAEF—Excluded variables from multivariable regression analysis.

(DOCX)

S5 Table. Active LAEF—Excluded variables from multivariable regression analysis.

(DOCX)

S6 Table. Passive LAEF—Excluded variables from multivariable regression analysis.

(DOCX)

S7 Table. Univariable linear regression analyses for total LAEF.

(DOCX)

S8 Table. Univariable linear regression analyses for active LAEF.

(DOCX)

S9 Table. Univariable linear regression analyses for passive LAEF.

(DOCX)

S10 Table. Comprehensive analysis of the entire cohort.

Baseline characteristics.

(DOCX)

S11 Table. Comprehensive analysis, AF Burden score.

Absolute and indexed minimum LA volume and LAEF_total were significantly different between groups while LAV_max was not.

(DOCX)

S12 Table. Comprehensive analysis, CHA2DS2VASc based stroke risk.

Absolute and indexed minimum LA volume and LAEF_total were significantly different between groups while LAV_max was not.

(DOCX)

S13 Table. Comprehensive analysis, AF type.

LA volumes (minimum and maximum) were higher and LAEF_total lower in patients with persistent AF.

(DOCX)

S14 Table. Comprehensive analysis, EHRA score.

We did not find significant differences between EHRA Score and LA measures.

(DOCX)

S1 Data. Minimal data set.

(XLSX)

Data Availability Statement

We have added a minimal data set of all participants and parameters used for the statistical analysis. There are restrictions on accessing the MRI data. In order to apply for access to the MRI data, please reach out to: Rebecca Paladini Project Coordinator Swiss-AF Petersgraben 4 4031 Basel Switzerland Email: Rebecca.Paladini@usb.ch.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES